Celanese (CE) Financials

$58.96 +1.79 (+3.12%)

As of 11:43 AM Eastern

Annual Income Statements for Celanese

This table shows Celanese's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	304	900	843	1,207	852	1,985	1,890	1,894	1,943	-1,542	-1,165
Consolidated Net Income / (Loss)	285	906	849	1,213	858	1,992	1,896	1,902	1,947	-1,534	-1,151
Net Income / (Loss) Continuing Operations	287	908	862	1,218	864	2,004	1,918	1,910	1,956	-1,526	-1,130
Total Pre-Tax Income	488	1,030	1,075	1,510	988	2,251	2,248	1,421	1,161	-1,019	-1,220
Total Operating Income	326	934	858	1,334	834	664	1,946	1,378	1,665	-720	-786
Total Gross Profit	1,318	1,405	1,511	1,972	1,606	1,293	2,682	2,380	2,583	2,336	1,952
Total Revenue	5,674	5,389	6,140	7,155	6,297	5,655	8,537	9,673	10,926	10,268	9,544
Operating Revenue	5,674	5,389	6,140	7,155	6,297	5,655	8,537	9,673	10,926	10,268	9,544
Total Cost of Revenue	4,356	3,984	4,629	5,183	4,691	4,362	5,855	7,293	8,343	7,932	7,592
Operating Cost of Revenue	4,356	3,984	4,629	5,183	4,691	4,362	5,855	7,293	8,343	7,932	7,592
Total Operating Expenses	992	471	653	638	772	629	736	1,007	918	3,056	2,738
Selling, General & Admin Expense	506	378	496	546	483	482	633	824	1,077	1,033	899
Research & Development Expense	119	78	73	72	67	74	86	112	146	130	125
Amortization Expense	11	9.00	20	24	24	22	25	62	164	159	164
Other Operating Expenses / (Income)	-4.00	1.00	-	-	-7.00	5.00	-2.00	1.00	-32	-24	-36
Other Special Charges / (Income)	360	5.00	64	-4.00	205	46	-6.00	8.00	-437	1,758	1,586
Total Other Income / (Expense), net	162	96	217	176	154	1,587	302	43	-504	-299	-434
Interest Expense	119	126	122	126	119	109	100	405	727	676	769
Interest & Investment Income	289	265	293	356	301	1,674	301	422	267	357	273
Other Income / (Expense), net	-8.00	-43	46	-54	-28	22	101	26	-44	20	62
Income Tax Expense	201	122	213	292	124	247	330	-489	-795	507	-90
Net Income / (Loss) Discontinued Operations	-2.00	-2.00	-13	-5.00	-6.00	-12	-22	-8.00	-9.00	-8.00	-21
Net Income / (Loss) Attributable to Noncontrolling Interest	-19	6.00	6.00	6.00	6.00	7.00	6.00	8.00	4.00	8.00	14
Basic Earnings per Share	$2.02	$6.21	$6.11	$8.99	$6.88	$16.85	$16.99	$17.48	$17.85	($14.11)	($10.64)
Weighted Average Basic Shares Outstanding	150.84M	144.94M	137.90M	134.31M	123.93M	117.82M	111.22M	108.38M	108.85M	109.27M	109.53M
Diluted Earnings per Share	$2.00	$6.18	$6.09	$8.91	$6.84	$16.75	$16.86	$17.34	$17.76	($14.11)	($10.64)
Weighted Average Diluted Shares Outstanding	152.29M	145.67M	138.32M	135.42M	124.65M	118.48M	112.08M	109.24M	109.38M	109.27M	109.53M
Weighted Average Basic & Diluted Shares Outstanding	150.50M	144.90M	138M	134.30M	119.56M	228.35M	216.06M	216.95M	217.81M	109.33M	109.57M

This table shows Celanese's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	951	698	121	155	113	-1,914	-24	199	-1,357	14	44
Consolidated Net Income / (Loss)	949	701	124	153	117	-1,911	-20	202	-1,353	17	48
Net Income / (Loss) Continuing Operations	950	707	124	154	119	-1,906	-15	212	-1,353	23	49
Total Pre-Tax Income	714	132	157	183	180	-1,519	-6.00	135	-1,360	8.00	82
Total Operating Income	842	259	210	250	245	-1,405	165	233	-1,275	88	214
Total Gross Profit	673	613	554	641	619	539	474	535	521	420	468
Total Revenue	2,723	2,569	2,611	2,651	2,648	2,370	2,389	2,532	2,419	2,204	2,337
Operating Revenue	2,723	2,569	2,611	2,651	2,648	2,370	2,389	2,532	2,419	2,204	2,337
Total Cost of Revenue	2,050	1,956	2,057	2,010	2,029	1,831	1,915	1,997	1,898	1,784	1,869
Operating Cost of Revenue	2,050	1,956	2,057	2,010	2,029	1,831	1,915	1,997	1,898	1,784	1,869
Total Operating Expenses	-169	354	344	391	374	1,945	309	302	1,796	332	254
Selling, General & Admin Expense	244	272	265	255	248	262	231	213	231	225	226
Research & Development Expense	32	32	34	33	32	31	31	31	31	32	28
Amortization Expense	41	40	41	38	40	40	40	42	42	40	40
Other Operating Expenses / (Income)	0.00	-11	-11	9.00	-10	-12	-21	-6.00	-2.00	-7.00	-12
Other Special Charges / (Income)	-486	21	15	56	64	1,624	28	22	1,494	42	-28
Total Other Income / (Expense), net	-128	-127	-53	-67	-65	-114	-171	-98	-85	-80	-132
Interest Expense	185	178	169	174	169	164	202	177	177	213	183
Interest & Investment Income	54	95	102	92	86	77	27	77	86	83	45
Other Income / (Expense), net	3.00	-44	14	15	18	-27	4.00	2.00	6.00	50	6.00
Income Tax Expense	-236	-575	33	29	61	387	9.00	-77	-7.00	-15	33
Net Income / (Loss) Discontinued Operations	-1.00	-6.00	0.00	-1.00	-2.00	-5.00	-5.00	-10	0.00	-6.00	-1.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-2.00	3.00	3.00	-2.00	4.00	3.00	4.00	3.00	4.00	3.00	4.00
Basic Earnings per Share	$8.73	$6.42	$1.11	$1.42	$1.03	($17.52)	($0.22)	$1.82	($12.39)	$0.12	$0.40
Weighted Average Basic Shares Outstanding	108.92M	108.85M	109.07M	109.31M	109.34M	109.27M	109.42M	109.53M	109.57M	109.53M	109.66M
Diluted Earnings per Share	$8.69	$6.39	$1.10	$1.41	$1.03	($17.50)	($0.22)	$1.81	($12.39)	$0.13	$0.40
Weighted Average Diluted Shares Outstanding	109.44M	109.38M	109.51M	109.55M	109.54M	109.27M	109.42M	109.73M	109.57M	109.53M	109.98M
Weighted Average Basic & Diluted Shares Outstanding	108.86M	217.81M	109.22M	109.26M	109.31M	109.33M	109.41M	109.50M	109.50M	109.57M	109.66M

This table details how cash moves in and out of Celanese's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	187	-329	-62	-114	24	492	-419	972	297	-843	301
Net Cash From Operating Activities	862	893	803	1,558	1,454	1,343	1,757	1,819	1,899	966	1,146
Net Cash From Continuing Operating Activities	864	891	795	1,568	1,454	1,338	1,742	1,847	1,901	971	1,134
Net Income / (Loss) Continuing Operations	285	906	849	1,213	858	1,992	1,896	1,902	1,947	-1,534	-1,151
Consolidated Net Income / (Loss)	285	906	849	1,213	858	1,992	1,896	1,902	1,947	-1,534	-1,151
Depreciation Expense	363	295	310	349	356	356	378	478	739	823	786
Amortization Expense	127	103	46	165	-	-	41	81	66	37	-45
Non-Cash Adjustments To Reconcile Net Income	51	-393	-443	-74	102	-1,385	-126	-70	-426	1,594	1,506
Changes in Operating Assets and Liabilities, net	38	-20	33	-85	138	375	-447	-544	-425	51	38
Net Cash From Discontinued Operating Activities	-2.00	2.00	8.00	-10	0.00	5.00	15	-28	-2.00	-5.00	12
Net Cash From Investing Activities	-558	-439	-549	-507	-493	592	-1,119	-11,141	-134	-470	-349
Net Cash From Continuing Investing Activities	-558	-439	-549	-507	-493	592	-1,119	-11,141	-134	-470	-349
Purchase of Property, Plant & Equipment	-520	-246	-267	-337	-370	-364	-467	-543	-568	-435	-343
Acquisitions	-6.00	-178	-269	-144	-91	-100	-1,142	-10,589	52	0.00	0.00
Divestitures	-	-	-	0.00	0.00	1,575	-	48	480	0.00	21
Sale and/or Maturity of Investments	-	-	-	0.00	0.00	43	516	0.00	0.00	17	0.00
Other Investing Activities, net	-36	-27	-14	-39	-17	-39	-53	-57	-98	-52	-27
Net Cash From Financing Activities	-66	-759	-351	-1,165	-935	-1,471	-1,042	10,290	-1,456	-1,313	-513
Net Cash From Continuing Financing Activities	-66	-759	-351	-1,165	-935	-1,471	-1,042	10,290	-1,456	-1,313	-513
Repayment of Debt	-119	-1,250	-228	-669	-244	-810	-835	-688	-4,315	-1,476	-5,436
Payment of Dividends	40	-225	-268	-303	-310	-322	-331	-310	-316	-340	-43
Issuance of Debt	430	1,210	644	612	616	311	1,196	11,305	3,175	503	4,966
Effect of Exchange Rate Changes	-51	-24	35	-	-2.00	28	-	4.00	-12	-26	17

This table details how cash moves in and out of Celanese's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	61	448	-322	-298	-372	149	-11	222	267	-177	495
Net Cash From Operating Activities	403	830	101	292	79	494	37	410	447	252	76
Net Cash From Continuing Operating Activities	404	827	109	293	76	493	33	406	449	246	89
Net Income / (Loss) Continuing Operations	949	701	124	153	120	-1,911	-20	202	-1,358	22	48
Consolidated Net Income / (Loss)	949	701	124	153	120	-1,911	-20	202	-1,358	22	48
Depreciation Expense	185	195	227	198	209	189	191	193	201	201	208
Non-Cash Adjustments To Reconcile Net Income	-456	34	-29	30	4.00	1,589	0.00	-11	1,489	28	-37
Changes in Operating Assets and Liabilities, net	-274	-169	-213	-88	-257	589	-138	22	117	40	-130
Net Cash From Discontinued Operating Activities	-1.00	3.00	-8.00	-1.00	3.00	1.00	4.00	4.00	-2.00	6.00	-13
Net Cash From Investing Activities	375	-168	-151	-91	-100	-128	-98	-88	-59	-104	425
Net Cash From Continuing Investing Activities	375	-168	-151	-91	-100	-128	-98	-88	-59	-104	425
Purchase of Property, Plant & Equipment	-131	-128	-137	-105	-88	-105	-102	-93	-64	-84	-66
Divestitures	471	-	0.00	-	4.00	-	6.00	1.00	-	14	493
Other Investing Activities, net	-17	-40	-14	1.00	-16	-23	-2.00	4.00	5.00	-34	-2.00
Net Cash From Financing Activities	-700	-240	-259	-489	-376	-189	45	-116	-118	-324	-3.00
Net Cash From Continuing Financing Activities	-700	-240	-259	-489	-376	-189	45	-116	-118	-324	-3.00
Repayment of Debt	-3,446	-163	-446	-484	-542	-15	-3,231	-234	-232	-1,743	-59
Payment of Dividends	-80	-77	-81	-91	-83	-85	-11	-9.00	-11	-12	-10
Issuance of Debt	2,826	-	267	86	249	-89	3,287	127	125	1,431	66
Effect of Exchange Rate Changes	-17	26	-13	-10	25	-28	5.00	16	-3.00	-1.00	-3.00

This table presents Celanese's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	8,586	8,357	1,579	9,313	9,476	10,909	11,975	26,272	26,597	22,838	21,695
Total Current Assets	2,787	2,472	576	2,874	2,765	3,763	3,807	6,611	6,218	5,126	5,693
Cash & Equivalents	967	638	576	439	463	955	536	1,508	1,805	962	1,263
Note & Lease Receivable	285	223	-	301	331	450	506	675	541	493	545
Accounts Receivable	706	801	-	1,017	850	792	1,161	1,379	1,243	1,121	922
Inventories, net	682	720	-	1,046	1,038	978	1,524	2,808	2,357	2,284	2,220
Other Current Assets	49	60	-	40	43	55	80	241	272	266	251
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	-	0.00	492
Plant, Property, & Equipment, net	3,609	3,577	0.00	3,719	3,713	3,939	4,193	5,584	5,584	5,273	5,076
Total Noncurrent Assets	2,190	2,308	1,003	2,720	2,998	3,207	3,975	14,077	14,795	12,439	10,926
Long-Term Investments	838	852	-	979	975	820	823	1,062	1,220	1,217	1,252
Goodwill	705	796	1,003	1,057	1,074	1,166	1,412	7,142	6,977	5,387	4,171
Intangible Assets	125	194	-	310	312	319	735	4,105	3,975	3,641	3,184
Noncurrent Deferred & Refundable Income Taxes	222	159	-	84	96	259	248	808	1,677	1,251	1,359
Other Noncurrent Operating Assets	300	307	-	290	541	643	757	960	946	943	960
Total Liabilities & Shareholders' Equity	8,586	8,357	-177	9,313	9,476	10,909	11,975	26,272	26,597	22,838	21,695
Total Liabilities	5,757	5,336	0.00	5,934	6,578	7,014	7,438	20,167	19,045	17,275	17,223
Total Current Liabilities	1,550	1,077	0.00	1,779	1,754	1,973	2,505	4,068	4,072	3,890	3,683
Short-Term Debt	513	118	-	561	496	496	791	1,306	1,383	1,501	1,204
Accounts Payable	587	625	-	819	780	797	1,160	1,518	1,510	1,228	1,279
Current Deferred & Payable Income Tax Liabilities	120	12	-	56	17	0.00	81	43	25	4.00	76
Other Current Liabilities	330	322	-	343	461	680	473	1,201	1,154	1,157	1,049
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	0.00	75
Total Noncurrent Liabilities	4,207	4,259	0.00	4,155	4,824	5,041	4,933	16,099	14,973	13,385	13,540
Long-Term Debt	2,468	2,890	-	2,970	3,409	3,227	3,176	13,373	12,301	11,078	11,394
Noncurrent Deferred & Payable Income Tax Liabilities	303	261	-	413	422	749	835	1,564	1,299	1,209	720
Noncurrent Employee Benefit Liabilities	1,189	893	-	564	589	643	558	411	457	396	344
Other Noncurrent Operating Liabilities	247	215	-	208	404	422	364	751	916	702	1,082
Commitments & Contingencies	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,829	3,021	3,299	3,379	2,898	3,895	4,537	6,105	7,552	5,563	4,472
Total Preferred & Common Equity	2,378	2,588	2,887	2,984	2,507	3,526	4,189	5,637	7,091	5,129	4,049
Total Common Equity	2,378	2,588	-177	2,984	2,507	3,526	4,189	5,637	7,091	5,129	4,049
Common Stock	136	157	-	233	254	257	333	372	394	409	431
Retained Earnings	3,621	4,320	-	5,847	6,399	8,091	9,677	11,274	12,929	11,054	9,876
Treasury Stock	-1,031	-1,531	-	-2,849	-3,846	-4,494	-5,492	-5,491	-5,488	-5,486	-5,482
Accumulated Other Comprehensive Income / (Loss)	-348	-358	-177	-247	-300	-328	-329	-518	-744	-848	-776
Noncontrolling Interest	451	433	-	395	391	369	348	468	461	434	423

This table presents Celanese's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	25,649	25,538	26,597	26,033	25,812	25,892	22,857	23,197	23,713	22,169	21,735
Total Current Assets	6,252	5,887	6,218	5,945	5,904	5,706	5,145	5,418	5,675	6,090	5,969
Cash & Equivalents	1,296	1,357	1,805	1,483	1,185	813	962	951	1,173	1,440	1,758
Note & Lease Receivable	625	570	541	536	662	688	493	640	703	657	583
Accounts Receivable	1,338	1,339	1,243	1,289	1,264	1,367	1,121	1,240	1,216	1,038	1,097
Inventories, net	2,514	2,337	2,357	2,354	2,464	2,562	2,284	2,309	2,288	2,213	2,284
Other Current Assets	268	284	272	283	329	276	285	278	295	271	247
Other Current Nonoperating Assets	211	-	-	-	-	-	-	-	-	471	0.00
Plant, Property, & Equipment, net	5,541	5,467	5,584	5,471	5,382	5,431	5,273	5,259	5,303	5,172	4,938
Total Noncurrent Assets	13,856	14,184	14,795	14,617	14,526	14,755	12,439	12,520	12,735	10,907	10,828
Long-Term Investments	1,028	1,245	1,220	1,238	1,215	1,253	1,217	1,220	1,263	1,259	1,227
Goodwill	7,063	6,991	6,977	6,926	6,899	6,997	5,387	5,413	5,466	4,170	4,157
Intangible Assets	4,007	3,944	3,975	3,902	3,844	3,858	3,641	3,670	3,772	3,213	3,119
Noncurrent Deferred & Refundable Income Taxes	832	1,074	1,677	1,618	1,608	1,672	1,251	1,295	1,321	1,347	1,341
Other Noncurrent Operating Assets	926	930	946	933	960	975	943	922	913	918	984
Total Liabilities & Shareholders' Equity	25,649	25,538	26,597	26,033	25,812	25,892	22,857	23,197	23,713	22,169	21,735
Total Liabilities	19,561	18,589	19,045	18,502	18,203	18,174	17,248	17,582	18,009	17,790	17,250
Total Current Liabilities	3,922	3,616	4,072	4,925	4,626	4,159	3,853	2,797	2,767	3,727	4,316
Short-Term Debt	1,507	1,408	1,383	2,439	1,977	1,607	1,501	406	252	1,199	1,741
Accounts Payable	1,243	1,263	1,510	1,447	1,538	1,446	1,228	1,314	1,283	1,248	1,441
Current Deferred & Payable Income Tax Liabilities	7.00	18	25	28	5.00	23	4.00	80	95	47	94
Other Current Liabilities	1,146	927	1,154	1,011	1,106	1,083	1,120	997	1,137	1,171	1,040
Other Current Nonoperating Liabilities	19	-	-	-	-	-	-	-	-	62	0.00
Total Noncurrent Liabilities	15,639	14,973	14,973	13,577	13,577	14,015	13,395	14,785	15,242	14,063	12,934
Long-Term Debt	12,889	12,291	12,301	11,018	11,058	11,324	11,078	12,378	12,689	11,655	10,813
Noncurrent Deferred & Payable Income Tax Liabilities	1,505	1,499	1,299	1,314	1,331	1,314	1,219	1,215	930	899	737
Noncurrent Employee Benefit Liabilities	406	396	457	444	435	440	396	396	411	402	332
Other Noncurrent Operating Liabilities	839	787	916	801	753	937	702	796	1,212	1,107	1,052
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	6,088	6,949	7,552	7,531	7,609	7,718	5,609	5,615	5,704	4,379	4,485
Total Preferred & Common Equity	5,624	6,491	7,091	7,071	7,166	7,274	5,175	5,186	5,276	3,954	4,063
Total Common Equity	5,624	6,491	7,091	7,071	7,166	7,274	5,175	5,186	5,276	3,954	4,063
Common Stock	383	386	394	383	394	397	409	413	419	425	439
Retained Earnings	11,433	12,308	12,929	12,973	13,051	13,091	11,100	11,076	11,243	9,861	9,917
Treasury Stock	-5,490	-5,490	-5,488	-5,488	-5,487	-5,487	-5,486	-5,486	-5,483	-5,483	-5,482
Accumulated Other Comprehensive Income / (Loss)	-702	-713	-744	-797	-792	-727	-848	-817	-903	-849	-811
Noncontrolling Interest	464	458	461	460	443	444	434	429	428	425	422

This table displays calculated financial ratios and metrics derived from Celanese's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-16.58%	-5.02%	13.94%	16.53%	-11.99%	-10.20%	50.96%	13.31%	13.10%	-6.03%	-7.05%
EBITDA Growth	-42.37%	59.53%	-2.25%	42.38%	-35.23%	-10.33%	136.66%	-20.40%	24.71%	-92.52%	-89.38%
EBIT Growth	-57.82%	180.19%	1.46%	41.59%	-37.03%	-14.89%	198.40%	-31.41%	17.02%	-141.21%	-3.43%
NOPAT Growth	-62.04%	329.45%	-16.44%	56.40%	-32.22%	-18.95%	180.87%	11.56%	51.90%	-117.34%	-9.17%
Net Income Growth	-54.03%	217.89%	-6.29%	42.87%	-29.27%	132.17%	-4.82%	0.32%	3.26%	-177.09%	24.97%
EPS Growth	-50.00%	209.00%	-1.46%	46.31%	-23.23%	144.88%	0.66%	2.85%	3.34%	-177.73%	24.59%
Operating Cash Flow Growth	-10.40%	3.60%	-10.08%	94.02%	-6.68%	-7.63%	30.83%	3.53%	4.40%	-49.13%	18.63%
Free Cash Flow Firm Growth	14.07%	-12.24%	1,349.35%	-180.64%	125.59%	-29.95%	-128.82%	-5,176.77%	130.56%	-39.14%	-26.90%
Invested Capital Growth	-3.36%	13.43%	-77.76%	444.47%	-2.49%	-0.28%	34.56%	154.92%	-0.02%	-12.09%	-11.43%
Revenue Q/Q Growth	-3.81%	-0.43%	4.81%	1.36%	-3.92%	2.89%	8.71%	0.76%	2.06%	-1.90%	-1.71%
EBITDA Q/Q Growth	-10.12%	61.93%	14.34%	4.67%	-10.06%	23.46%	17.37%	-15.61%	14.61%	-89.83%	101.12%
EBIT Q/Q Growth	-44.21%	90.79%	13.14%	-7.04%	-13.89%	40.57%	18.19%	-26.42%	14.73%	-169.79%	68.40%
NOPAT Q/Q Growth	-52.33%	136.74%	4.84%	-1.05%	-12.86%	34.37%	16.77%	23.52%	-8.65%	-129.85%	65.47%
Net Income Q/Q Growth	-43.11%	104.05%	5.34%	-7.83%	-6.13%	241.68%	-32.86%	14.65%	-3.35%	-237.89%	62.58%
EPS Q/Q Growth	-41.00%	98.71%	5.91%	-7.38%	-4.87%	242.54%	-30.99%	15.22%	-3.29%	-239.86%	62.32%
Operating Cash Flow Q/Q Growth	-3.36%	-17.01%	15.04%	24.34%	-2.48%	-3.73%	21.42%	-2.31%	17.95%	-25.81%	-17.44%
Free Cash Flow Firm Q/Q Growth	76.14%	-57.62%	1,094.46%	-739.95%	-22.53%	27.89%	-120.01%	-2,515.46%	135.38%	56.21%	-55.50%
Invested Capital Q/Q Growth	-8.64%	12.28%	-80.31%	-3.40%	-0.89%	-0.54%	21.35%	159.98%	0.91%	-13.85%	0.09%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	23.23%	26.07%	24.61%	27.56%	25.50%	22.86%	31.42%	24.60%	23.79%	22.92%	20.45%
EBITDA Margin	14.24%	23.92%	20.52%	25.07%	18.45%	18.43%	28.89%	20.29%	22.38%	1.78%	0.18%
Operating Margin	5.75%	17.33%	13.97%	18.64%	13.24%	11.74%	22.79%	14.25%	15.42%	-6.78%	-8.24%
EBIT Margin	5.60%	16.53%	14.72%	17.89%	12.80%	12.13%	23.98%	14.51%	15.02%	-6.59%	-7.59%
Profit (Net Income) Margin	5.02%	16.81%	13.83%	16.95%	13.63%	35.23%	22.21%	19.66%	17.95%	-14.73%	-12.06%
Tax Burden Percent	58.40%	87.96%	78.98%	80.33%	86.84%	88.49%	84.34%	133.85%	166.02%	152.01%	94.34%
Interest Burden Percent	153.46%	115.60%	118.92%	117.97%	122.58%	328.13%	109.82%	101.21%	72.00%	147.12%	168.51%
Effective Tax Rate	41.19%	11.84%	19.81%	19.34%	12.55%	10.97%	14.68%	-34.41%	-66.78%	0.00%	0.00%
Return on Invested Capital (ROIC)	4.74%	19.41%	24.96%	33.29%	13.52%	11.12%	26.66%	14.61%	15.45%	-2.85%	-3.66%
ROIC Less NNEP Spread (ROIC-NNEP)	13.29%	25.68%	-14.89%	-94.71%	19.23%	84.04%	38.38%	15.28%	7.99%	-12.60%	-9.64%
Return on Net Nonoperating Assets (RNNOA)	4.91%	11.56%	1.90%	3.04%	13.81%	47.53%	18.31%	21.14%	13.31%	-20.16%	-19.28%
Return on Equity (ROE)	9.65%	30.97%	26.87%	36.33%	27.34%	58.65%	44.97%	35.75%	28.76%	-23.01%	-22.94%
Cash Return on Invested Capital (CROIC)	8.15%	6.82%	152.18%	-104.64%	16.05%	11.40%	-2.80%	-72.69%	15.47%	10.02%	8.47%
Operating Return on Assets (OROA)	3.66%	10.52%	18.20%	23.50%	8.58%	6.73%	17.89%	7.34%	6.22%	-2.74%	-3.25%
Return on Assets (ROA)	3.28%	10.69%	17.09%	22.27%	9.13%	19.54%	16.57%	9.95%	7.43%	-6.12%	-5.17%
Return on Common Equity (ROCE)	8.49%	26.29%	10.25%	15.27%	23.91%	52.09%	41.15%	33.00%	26.81%	-21.44%	-20.98%
Return on Equity Simple (ROE_SIMPLE)	11.98%	35.01%	29.41%	40.65%	34.22%	56.49%	45.26%	33.74%	27.70%	-29.26%	0.00%
Net Operating Profit after Tax (NOPAT)	192	823	688	1,076	729	591	1,660	1,852	2,814	-488	-550
NOPAT Margin	3.38%	15.28%	11.21%	15.04%	11.58%	10.45%	19.45%	19.15%	25.72%	-4.75%	-5.76%
Net Nonoperating Expense Percent (NNEP)	-8.55%	-6.27%	39.85%	128.01%	-5.71%	-72.92%	-11.72%	-0.68%	7.46%	9.75%	5.99%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	8.91%	13.25%	-2.68%	-3.22%
Cost of Revenue to Revenue	76.77%	73.93%	75.39%	72.44%	74.50%	77.14%	68.58%	75.40%	76.21%	77.08%	79.55%
SG&A Expenses to Revenue	8.92%	7.01%	8.08%	7.63%	7.67%	8.52%	7.41%	8.52%	9.83%	10.02%	9.42%
R&D to Revenue	2.10%	1.45%	1.19%	1.01%	1.06%	1.31%	1.01%	1.16%	1.33%	1.26%	1.31%
Operating Expenses to Revenue	17.48%	8.74%	10.64%	8.92%	12.26%	11.12%	8.62%	10.41%	8.37%	29.70%	28.69%
Earnings before Interest and Taxes (EBIT)	318	891	904	1,280	806	686	2,047	1,404	1,643	-677	-724
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	808	1,289	1,260	1,794	1,162	1,042	2,466	1,963	2,448	183	17
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.45	3.70	0.00	3.55	5.35	3.98	4.11	1.88	2.34	1.46	1.14
Price to Tangible Book Value (P/TBV)	5.30	5.98	0.00	6.56	11.95	6.87	8.43	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.45	1.77	2.04	1.48	2.13	2.48	2.02	1.10	1.52	0.74	0.48
Price to Earnings (P/E)	26.99	10.63	14.88	8.78	15.73	7.07	9.11	5.60	8.46	0.00	0.00
Dividend Yield	2.06%	2.07%	1.88%	2.62%	2.16%	2.07%	1.72%	2.80%	1.84%	4.05%	0.28%
Earnings Yield	3.71%	9.41%	6.72%	11.38%	6.36%	14.15%	10.98%	17.85%	11.82%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.47	2.55	11.94	2.40	3.05	2.98	2.82	1.27	1.52	1.15	1.07
Enterprise Value to Revenue (EV/Rev)	1.73	2.13	1.95	1.83	2.58	2.80	2.36	2.40	2.53	1.79	1.59
Enterprise Value to EBITDA (EV/EBITDA)	12.13	8.91	9.50	7.29	13.96	15.18	8.18	11.81	11.32	100.54	890.19
Enterprise Value to EBIT (EV/EBIT)	30.82	12.89	13.24	10.22	20.12	23.05	9.85	16.51	16.86	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	51.12	13.95	17.40	12.16	22.24	26.75	12.15	12.52	9.85	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	11.37	12.86	14.91	8.40	11.15	11.77	11.48	12.75	14.59	19.05	13.21
Enterprise Value to Free Cash Flow (EV/FCFF)	29.73	39.69	2.85	0.00	18.74	26.09	0.00	0.00	9.84	10.73	11.87
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.05	1.00	0.00	1.05	1.35	0.96	0.87	2.40	1.81	2.24	2.82
Long-Term Debt to Equity	0.87	0.96	0.00	0.88	1.18	0.83	0.70	2.19	1.63	1.98	2.55
Financial Leverage	0.37	0.45	-0.13	-0.03	0.72	0.57	0.48	1.38	1.67	1.60	2.00
Leverage Ratio	2.94	2.90	1.57	1.63	2.99	3.00	2.71	3.59	3.87	3.76	4.44
Compound Leverage Factor	4.52	3.35	1.87	1.92	3.67	9.85	2.98	3.64	2.79	5.53	7.48
Debt to Total Capital	51.31%	49.89%	0.00%	51.10%	57.40%	48.87%	46.65%	70.63%	64.44%	69.16%	73.80%
Short-Term Debt to Total Capital	8.83%	1.96%	0.00%	8.12%	7.29%	6.51%	9.30%	6.28%	6.51%	8.25%	7.05%
Long-Term Debt to Total Capital	42.48%	47.94%	0.00%	42.98%	50.11%	42.36%	37.35%	64.34%	57.93%	60.91%	66.75%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.76%	7.18%	0.00%	5.72%	5.75%	4.84%	4.09%	2.25%	2.17%	2.39%	2.48%
Common Equity to Total Capital	40.93%	42.93%	-5.37%	43.18%	36.85%	46.29%	49.26%	27.12%	33.39%	28.45%	23.72%
Debt to EBITDA	3.69	2.33	0.00	1.97	3.36	3.57	1.61	7.48	5.59	68.74	741.06
Net Debt to EBITDA	1.42	1.15	0.00	1.16	2.09	1.36	1.06	6.17	4.35	56.83	593.12
Long-Term Debt to EBITDA	3.05	2.24	0.00	1.66	2.93	3.10	1.29	6.81	5.02	60.54	670.24
Debt to NOPAT	15.55	3.65	0.00	3.28	5.35	6.30	2.39	7.93	4.86	-25.78	-22.90
Net Debt to NOPAT	5.98	1.81	0.00	1.93	3.33	2.39	1.57	6.54	3.79	-21.32	-18.33
Long-Term Debt to NOPAT	12.87	3.51	0.00	2.76	4.67	5.46	1.91	7.22	4.37	-22.71	-20.71
Altman Z-Score	2.40	3.00	0.00	3.31	3.24	3.16	3.93	1.58	1.92	1.36	1.24
Noncontrolling Interest Sharing Ratio	12.04%	15.11%	61.85%	57.97%	12.52%	11.19%	8.50%	7.67%	6.80%	6.80%	8.54%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.80	2.30	0.00	1.62	1.58	1.91	1.52	1.63	1.53	1.34	1.55
Quick Ratio	1.28	1.57	0.00	1.01	0.96	1.38	0.88	0.88	0.88	0.67	0.74
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	330	289	4,194	-3,382	865	606	-175	-9,217	2,817	1,714	1,275
Operating Cash Flow to CapEx	167.05%	381.62%	301.88%	480.86%	394.04%	391.55%	399.32%	334.99%	334.33%	222.07%	334.11%
Free Cash Flow to Firm to Interest Expense	2.77	2.30	34.38	-26.84	7.27	5.56	-1.75	-22.76	3.87	2.54	1.66
Operating Cash Flow to Interest Expense	7.24	7.09	6.58	12.37	12.22	12.32	17.57	4.49	2.61	1.43	1.49
Operating Cash Flow Less CapEx to Interest Expense	2.91	5.23	4.40	9.79	9.12	9.17	13.17	3.15	1.83	0.79	1.04
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.65	0.64	1.24	1.31	0.67	0.55	0.75	0.51	0.41	0.42	0.43
Accounts Receivable Turnover	7.53	7.15	0.00	0.00	6.75	6.89	8.74	7.62	8.34	8.70	9.34
Inventory Turnover	5.95	5.68	0.00	0.00	4.50	4.33	4.68	3.37	3.23	3.41	3.37
Fixed Asset Turnover	1.55	1.50	0.00	0.00	1.69	1.48	2.10	1.98	1.96	1.89	1.84
Accounts Payable Turnover	6.48	6.57	0.00	0.00	5.87	5.53	5.98	5.45	5.51	5.79	6.06
Days Sales Outstanding (DSO)	48.47	51.04	0.00	0.00	54.11	52.99	41.75	47.92	43.74	41.97	39.07
Days Inventory Outstanding (DIO)	61.34	64.22	0.00	0.00	81.08	84.35	77.99	108.40	113.06	106.89	108.27
Days Payable Outstanding (DPO)	56.31	55.52	0.00	0.00	62.21	65.98	61.00	67.01	66.28	63.06	60.26
Cash Conversion Cycle (CCC)	53.50	59.74	0.00	0.00	72.98	71.36	58.74	89.31	90.52	85.80	87.07
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,975	4,509	1,003	5,461	5,325	5,310	7,145	18,214	18,211	16,009	14,138
Invested Capital Turnover	1.40	1.27	2.23	2.21	1.17	1.06	1.37	0.76	0.60	0.60	0.63
Increase / (Decrease) in Invested Capital	-138	534	-3,506	4,458	-136	-15	1,835	11,069	-3.00	-2,202	-1,825
Enterprise Value (EV)	9,802	11,484	11,971	13,080	16,219	15,813	20,170	23,186	27,702	18,399	15,133
Market Capitalization	8,205	9,563	12,547	10,603	13,401	14,029	17,214	10,609	16,582	7,565	4,627
Book Value per Share	$16.21	$18.07	($1.31)	$22.31	$20.74	$30.16	$38.48	$51.99	$65.14	$47.34	$36.98
Tangible Book Value per Share	$10.55	$11.16	($8.70)	$12.09	$9.27	$17.46	$18.76	($51.74)	($35.47)	($35.25)	($30.19)
Total Capital	5,810	6,029	3,299	6,910	6,803	7,618	8,504	20,784	21,236	18,188	17,070
Total Debt	2,981	3,008	0.00	3,531	3,905	3,723	3,967	14,679	13,684	12,579	12,598
Total Long-Term Debt	2,468	2,890	0.00	2,970	3,409	3,227	3,176	13,373	12,301	11,078	11,394
Net Debt	1,146	1,488	-576	2,082	2,427	1,415	2,608	12,109	10,659	10,400	10,083
Capital Expenditures (CapEx)	516	234	266	324	369	343	440	543	568	435	343
Debt-free, Cash-free Net Working Capital (DFCFNWC)	753	845	0.00	1,186	1,004	798	1,557	2,341	1,724	1,831	1,951
Debt-free Net Working Capital (DFNWC)	1,750	1,513	576	1,656	1,507	2,286	2,093	3,849	3,529	2,793	3,214
Net Working Capital (NWC)	1,237	1,395	576	1,095	1,011	1,790	1,302	2,543	2,146	1,292	2,010
Net Nonoperating Expense (NNE)	-93	-83	-161	-137	-129	-1,401	-236	-50	850	1,026	601
Net Nonoperating Obligations (NNO)	1,146	1,488	-2,296	2,082	2,427	1,415	2,608	12,109	10,659	10,400	9,666
Total Depreciation and Amortization (D&A)	490	398	356	514	356	356	419	559	805	860	741
Debt-free, Cash-free Net Working Capital to Revenue	13.27%	15.68%	0.00%	16.58%	15.94%	14.11%	18.24%	24.20%	15.76%	17.81%	20.44%
Debt-free Net Working Capital to Revenue	30.84%	28.08%	9.38%	23.14%	23.93%	40.42%	24.52%	39.79%	32.26%	27.17%	33.68%
Net Working Capital to Revenue	21.80%	25.89%	9.38%	15.30%	16.06%	31.65%	15.25%	26.29%	19.62%	12.57%	21.06%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.02	$6.21	$6.11	$8.99	$6.88	$16.85	$16.99	$17.48	$18.01	($13.93)	($10.64)
Adjusted Weighted Average Basic Shares Outstanding	150.84M	144.94M	137.90M	134.31M	123.93M	117.82M	111.22M	108.38M	108.85M	109.27M	109.53M
Adjusted Diluted Earnings per Share	$2.00	$6.18	$6.09	$8.91	$6.84	$16.75	$16.86	$17.34	$17.92	($13.93)	($10.64)
Adjusted Weighted Average Diluted Shares Outstanding	152.29M	145.67M	138.32M	135.42M	124.65M	118.48M	112.08M	109.24M	109.38M	109.27M	109.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	147.08M	140.93M	135.82M	128.10M	119.56M	228.35M	216.06M	216.95M	217.81M	109.33M	109.57M
Normalized Net Operating Profit after Tax (NOPAT)	403	828	739	1,073	909	632	1,655	970	875	743	560
Normalized NOPAT Margin	7.11%	15.36%	12.04%	14.99%	14.43%	11.18%	19.39%	10.03%	8.00%	7.22%	5.87%
Pre Tax Income Margin	8.60%	19.11%	17.51%	21.10%	15.69%	39.81%	26.33%	14.69%	10.81%	-9.69%	-12.78%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.67	7.07	7.41	10.16	6.77	6.29	20.47	3.47	2.26	-1.00	-0.94
NOPAT to Interest Expense	1.61	6.53	5.64	8.54	6.13	5.42	16.60	4.57	3.87	-0.72	-0.72
EBIT Less CapEx to Interest Expense	-1.66	5.21	5.23	7.59	3.67	3.15	16.07	2.13	1.48	-1.65	-1.39
NOPAT Less CapEx to Interest Expense	-2.73	4.68	3.46	5.97	3.03	2.28	12.20	3.23	3.09	-1.37	-1.16
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-14.04%	24.83%	31.57%	24.98%	36.13%	16.16%	17.46%	16.30%	16.09%	-22.46%	-3.74%
Augmented Payout Ratio	133.33%	80.02%	90.46%	91.34%	152.21%	48.80%	70.20%	17.19%	16.09%	-22.46%	-3.74%

This table displays calculated financial ratios and metrics derived from Celanese's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	109,571,972.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	109,571,972.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.40
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	18.34%	9.41%	-8.48%	-5.15%	-2.75%	-7.75%	-8.50%	-4.49%	-8.65%	-6.53%	-2.18%
EBITDA Growth	132.51%	150.00%	6.37%	-10.62%	-53.88%	-403.17%	-19.51%	-7.56%	-326.27%	126.84%	18.89%
EBIT Growth	150.00%	5,275.00%	-8.94%	-21.37%	-68.52%	-766.05%	-23.21%	-11.32%	-582.51%	109.50%	30.18%
NOPAT Growth	501.85%	3,438.83%	-16.71%	-38.34%	-85.24%	-170.90%	-29.10%	73.92%	-651.02%	125.36%	10.72%
Net Income Growth	391.71%	-8.84%	33.33%	-30.77%	-87.36%	-372.61%	-113.71%	32.03%	-1,256.41%	100.88%	340.00%
EPS Growth	396.57%	-8.71%	32.53%	-29.85%	-87.80%	-373.87%	-117.27%	28.37%	-1,302.91%	100.74%	281.82%
Operating Cash Flow Growth	-13.70%	53.42%	205.21%	-61.68%	-80.40%	-40.48%	-63.37%	40.41%	465.82%	-48.99%	105.41%
Free Cash Flow Firm Growth	-964.51%	112.60%	105.40%	99.36%	96.25%	-12.35%	262.54%	3,758.93%	1,050.73%	66.17%	6.84%
Invested Capital Growth	157.58%	-0.02%	-2.29%	1.54%	2.98%	-12.09%	-11.16%	-11.15%	-23.99%	-11.43%	-13.40%
Revenue Q/Q Growth	-2.58%	-5.66%	1.63%	1.53%	-0.11%	-10.50%	0.80%	5.99%	-4.46%	-8.89%	6.03%
EBITDA Q/Q Growth	98.84%	-60.19%	10.00%	2.66%	2.59%	-361.68%	129.20%	17.91%	-349.53%	131.74%	26.25%
EBIT Q/Q Growth	150.74%	-74.56%	4.19%	18.30%	0.38%	-638.35%	112.01%	36.63%	-640.00%	110.87%	59.42%
NOPAT Q/Q Growth	228.34%	23.82%	-88.04%	26.84%	-21.41%	-694.86%	111.96%	211.14%	-343.92%	128.35%	-49.46%
Net Income Q/Q Growth	329.41%	-26.13%	-82.31%	23.39%	-21.57%	-1,692.50%	99.11%	1,288.24%	-769.80%	101.26%	182.35%
EPS Q/Q Growth	332.34%	-26.47%	-82.79%	28.18%	-24.82%	-1,750.94%	98.91%	1,052.63%	-784.53%	101.05%	207.69%
Operating Cash Flow Q/Q Growth	-47.11%	105.96%	-87.83%	189.11%	-72.95%	525.32%	-92.51%	1,008.11%	9.02%	-43.62%	-69.84%
Free Cash Flow Firm Q/Q Growth	3.65%	114.01%	-57.21%	-111.03%	-466.41%	427.85%	76.99%	11.33%	48.51%	-41.72%	10.77%
Invested Capital Q/Q Growth	0.43%	0.91%	0.31%	-0.13%	1.86%	-13.85%	1.37%	-0.12%	-12.86%	0.09%	-0.59%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	24.72%	23.86%	21.22%	24.18%	23.49%	22.74%	19.92%	21.13%	21.54%	19.06%	20.03%
EBITDA Margin	37.83%	15.96%	17.27%	17.47%	17.94%	-52.45%	15.19%	16.90%	-44.15%	15.38%	18.31%
Operating Margin	30.92%	10.08%	8.04%	9.43%	9.37%	-59.28%	7.03%	9.20%	-52.71%	3.99%	9.16%
EBIT Margin	31.03%	8.37%	8.58%	10.00%	10.05%	-60.42%	7.20%	9.28%	-52.46%	6.26%	9.41%
Profit (Net Income) Margin	34.85%	27.29%	4.75%	5.77%	4.53%	-80.63%	-0.71%	7.98%	-55.93%	0.77%	2.05%
Tax Burden Percent	132.91%	531.06%	78.98%	83.61%	65.57%	125.81%	566.67%	149.63%	99.49%	212.50%	58.54%
Interest Burden Percent	84.50%	61.40%	70.09%	69.06%	68.80%	106.08%	-1.74%	57.45%	107.17%	5.80%	37.27%
Effective Tax Rate	-33.05%	-435.61%	21.02%	15.85%	33.33%	0.00%	0.00%	-57.04%	0.00%	-187.50%	40.24%
Return on Invested Capital (ROIC)	35.21%	32.44%	3.68%	4.63%	3.57%	-24.93%	2.87%	8.34%	-21.91%	7.28%	3.43%
ROIC Less NNEP Spread (ROIC-NNEP)	32.53%	26.41%	3.32%	4.12%	3.16%	-33.74%	1.61%	6.79%	-26.37%	4.93%	2.64%
Return on Net Nonoperating Assets (RNNOA)	34.04%	44.03%	5.66%	6.77%	4.73%	-53.99%	2.61%	10.78%	-44.94%	9.85%	5.27%
Return on Equity (ROE)	69.24%	76.46%	9.34%	11.39%	8.30%	-78.92%	5.48%	19.11%	-66.84%	17.13%	8.70%
Cash Return on Invested Capital (CROIC)	-63.55%	15.47%	16.94%	12.54%	5.99%	10.02%	8.82%	8.74%	17.52%	8.47%	10.95%
Operating Return on Assets (OROA)	14.19%	3.46%	3.52%	4.10%	4.09%	-25.12%	2.94%	3.73%	-21.20%	2.68%	3.98%
Return on Assets (ROA)	15.94%	11.29%	1.95%	2.37%	1.85%	-33.52%	-0.29%	3.20%	-22.60%	0.33%	0.87%
Return on Common Equity (ROCE)	64.71%	71.26%	8.70%	10.64%	7.79%	-73.56%	5.11%	17.86%	-62.04%	15.67%	7.97%
Return on Equity Simple (ROE_SIMPLE)	31.30%	0.00%	28.21%	26.89%	15.09%	0.00%	-31.91%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	1,120	1,387	166	210	165	-984	118	366	-893	253	128
NOPAT Margin	41.14%	54.00%	6.35%	7.94%	6.24%	-41.50%	4.92%	14.45%	-36.90%	11.48%	5.47%
Net Nonoperating Expense Percent (NNEP)	2.67%	6.03%	0.36%	0.51%	0.41%	8.81%	1.26%	1.55%	4.47%	2.35%	0.79%
Return On Investment Capital (ROIC_SIMPLE)	-	6.53%	-	-	-	-5.41%	0.64%	1.96%	-5.18%	1.48%	0.75%
Cost of Revenue to Revenue	75.28%	76.14%	78.78%	75.82%	76.51%	77.26%	80.08%	78.87%	78.46%	80.94%	79.97%
SG&A Expenses to Revenue	8.96%	10.59%	10.15%	9.62%	9.37%	11.05%	9.63%	8.41%	9.55%	10.21%	9.67%
R&D to Revenue	1.18%	1.25%	1.30%	1.24%	1.21%	1.31%	1.30%	1.22%	1.28%	1.45%	1.20%
Operating Expenses to Revenue	-6.21%	13.78%	13.14%	14.75%	14.12%	82.07%	12.89%	11.93%	74.25%	15.06%	10.87%
Earnings before Interest and Taxes (EBIT)	845	215	224	265	266	-1,432	172	235	-1,269	138	220
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,030	410	451	463	475	-1,243	363	428	-1,068	339	428
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.05	2.34	2.62	2.05	2.03	1.46	1.20	1.15	1.16	1.14	1.77
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.24	1.52	1.73	1.39	1.41	0.74	0.62	0.61	0.47	0.48	0.76
Price to Earnings (P/E)	6.56	8.46	9.31	7.61	13.55	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	2.29%	1.84%	1.65%	2.09%	2.07%	4.05%	3.75%	2.64%	1.88%	0.28%	0.18%
Earnings Yield	15.24%	11.82%	10.74%	13.13%	7.38%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.38	1.52	1.63	1.41	1.40	1.15	1.06	1.05	1.08	1.07	1.22
Enterprise Value to Revenue (EV/Rev)	2.32	2.53	2.78	2.44	2.49	1.79	1.71	1.71	1.56	1.59	1.81
Enterprise Value to EBITDA (EV/EBITDA)	11.64	11.32	12.34	10.93	14.50	100.54	297.32	738.41	0.00	890.19	132.26
Enterprise Value to EBIT (EV/EBIT)	17.37	16.86	18.34	16.61	26.89	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	8.08	9.85	11.00	10.11	15.96	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	15.45	14.59	14.18	15.83	20.03	19.05	19.12	16.65	10.94	13.21	14.51
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	9.84	9.49	11.33	23.77	10.73	11.33	11.28	5.30	11.87	10.37
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.97	1.81	1.79	1.71	1.68	2.24	2.28	2.27	2.94	2.82	2.80
Long-Term Debt to Equity	1.77	1.63	1.46	1.45	1.47	1.98	2.20	2.22	2.66	2.55	2.41
Financial Leverage	1.05	1.67	1.71	1.64	1.50	1.60	1.62	1.59	1.70	2.00	2.00
Leverage Ratio	3.83	3.87	3.82	3.76	3.51	3.76	3.74	3.72	3.97	4.44	4.45
Compound Leverage Factor	3.24	2.38	2.67	2.59	2.41	3.99	-0.07	2.14	4.26	0.26	1.66
Debt to Total Capital	66.35%	64.44%	64.12%	63.14%	62.62%	69.16%	69.48%	69.41%	74.59%	73.80%	73.68%
Short-Term Debt to Total Capital	6.82%	6.51%	11.62%	9.58%	7.78%	8.25%	2.21%	1.35%	6.96%	7.05%	10.22%
Long-Term Debt to Total Capital	59.53%	57.93%	52.50%	53.57%	54.84%	60.91%	67.28%	68.06%	67.63%	66.75%	63.46%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.22%	2.17%	2.19%	2.15%	2.15%	2.39%	2.33%	2.30%	2.47%	2.48%	2.48%
Common Equity to Total Capital	31.44%	33.39%	33.69%	34.71%	35.23%	28.45%	28.19%	28.30%	22.94%	23.72%	23.85%
Debt to EBITDA	6.41	5.59	5.59	5.54	7.19	68.74	220.41	562.65	-8.47	741.06	96.57
Net Debt to EBITDA	5.20	4.35	4.46	4.52	6.04	56.83	182.98	456.74	-6.69	593.12	73.61
Long-Term Debt to EBITDA	5.75	5.02	4.57	4.70	6.29	60.54	213.41	551.70	-7.68	670.24	83.18
Debt to NOPAT	4.45	4.86	4.98	5.12	7.91	-25.78	-24.71	-24.45	-8.07	-22.90	-24.33
Net Debt to NOPAT	3.60	3.79	3.97	4.18	6.65	-21.32	-20.52	-19.85	-6.37	-18.33	-18.55
Long-Term Debt to NOPAT	3.99	4.37	4.08	4.34	6.93	-22.71	-23.93	-23.98	-7.32	-20.71	-20.96
Altman Z-Score	1.74	1.74	1.78	1.69	1.71	1.25	1.47	1.46	1.16	1.37	1.45
Noncontrolling Interest Sharing Ratio	6.55%	6.80%	6.80%	6.62%	6.15%	6.80%	6.76%	6.54%	7.18%	8.54%	8.43%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.63	1.53	1.21	1.28	1.37	1.34	1.94	2.05	1.63	1.55	1.38
Quick Ratio	0.90	0.88	0.67	0.67	0.69	0.67	1.01	1.12	0.84	0.74	0.80
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-9,920	1,390	595	-66	-372	1,219	2,157	2,401	3,566	2,078	2,302
Operating Cash Flow to CapEx	307.63%	648.44%	73.72%	278.10%	89.77%	470.48%	36.27%	440.86%	698.44%	300.00%	115.15%
Free Cash Flow to Firm to Interest Expense	-53.62	7.81	3.52	-0.38	-2.20	7.43	10.68	13.56	20.14	9.76	12.58
Operating Cash Flow to Interest Expense	2.18	4.66	0.60	1.68	0.47	3.01	0.18	2.32	2.53	1.18	0.42
Operating Cash Flow Less CapEx to Interest Expense	1.47	3.94	-0.21	1.07	-0.05	2.37	-0.32	1.79	2.16	0.79	0.05
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.41	0.41	0.41	0.41	0.42	0.41	0.40	0.40	0.43	0.42
Accounts Receivable Turnover	8.72	8.34	7.39	8.11	7.75	8.70	7.95	8.02	8.07	9.34	8.12
Inventory Turnover	4.11	3.23	3.20	3.24	3.29	3.41	3.34	3.27	3.20	3.37	3.29
Fixed Asset Turnover	2.24	1.96	1.93	1.93	1.92	1.89	1.87	1.86	1.83	1.84	1.86
Accounts Payable Turnover	6.98	5.51	5.65	5.81	5.94	5.79	5.64	5.51	5.67	6.06	5.48
Days Sales Outstanding (DSO)	41.87	43.74	49.39	44.99	47.13	41.97	45.89	45.54	45.20	39.07	44.93
Days Inventory Outstanding (DIO)	88.79	113.06	113.96	112.53	111.08	106.89	109.38	111.66	114.12	108.27	111.08
Days Payable Outstanding (DPO)	52.29	66.28	64.59	62.87	61.42	63.06	64.77	66.28	64.39	60.26	66.63
Cash Conversion Cycle (CCC)	78.37	90.52	98.76	94.66	96.78	85.80	90.50	90.91	94.94	87.07	89.38
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	18,046	18,211	18,267	18,244	18,583	16,009	16,228	16,209	14,125	14,138	14,054
Invested Capital Turnover	0.86	0.60	0.58	0.58	0.57	0.60	0.58	0.58	0.59	0.63	0.63
Increase / (Decrease) in Invested Capital	11,040	-3.00	-429	276	537	-2,202	-2,039	-2,035	-4,458	-1,825	-2,174
Enterprise Value (EV)	24,871	27,702	29,725	25,737	26,083	18,399	17,245	16,983	15,185	15,133	17,194
Market Capitalization	13,316	16,582	18,529	14,659	14,774	7,565	6,203	6,050	4,605	4,627	7,203
Book Value per Share	$59.63	$65.14	$64.83	$65.61	$66.57	$47.34	$47.43	$48.22	$36.11	$36.98	$37.08
Tangible Book Value per Share	($40.83)	($35.47)	($34.45)	($32.75)	($32.77)	($35.25)	($35.64)	($36.21)	($31.31)	($30.19)	($29.32)
Total Capital	20,648	21,236	20,988	20,644	20,649	18,188	18,399	18,645	17,233	17,070	17,039
Total Debt	13,699	13,684	13,457	13,035	12,931	12,579	12,784	12,941	12,854	12,598	12,554
Total Long-Term Debt	12,291	12,301	11,018	11,058	11,324	11,078	12,378	12,689	11,655	11,394	10,813
Net Debt	11,097	10,659	10,736	10,635	10,865	10,400	10,613	10,505	10,155	10,083	9,569
Capital Expenditures (CapEx)	131	128	137	105	88	105	102	93	64	84	66
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,322	1,724	1,976	2,070	2,341	1,831	2,076	1,987	2,122	1,951	1,636
Debt-free Net Working Capital (DFNWC)	3,679	3,529	3,459	3,255	3,154	2,793	3,027	3,160	3,562	3,214	3,394
Net Working Capital (NWC)	2,271	2,146	1,020	1,278	1,547	1,292	2,621	2,908	2,363	2,010	1,653
Net Nonoperating Expense (NNE)	171	686	42	57	45	928	135	164	461	236	80
Net Nonoperating Obligations (NNO)	11,097	10,659	10,736	10,635	10,865	10,400	10,613	10,505	9,746	9,666	9,569
Total Depreciation and Amortization (D&A)	185	195	227	198	209	189	191	193	201	201	208
Debt-free, Cash-free Net Working Capital to Revenue	21.66%	15.76%	18.47%	19.61%	22.34%	17.81%	20.64%	19.99%	21.85%	20.44%	17.24%
Debt-free Net Working Capital to Revenue	34.32%	32.26%	32.33%	30.84%	30.10%	27.17%	30.10%	31.79%	36.68%	33.68%	35.76%
Net Working Capital to Revenue	21.19%	19.62%	9.53%	12.11%	14.76%	12.57%	26.06%	29.26%	24.34%	21.06%	17.41%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$8.73	$6.42	$1.11	$1.42	$1.06	($17.52)	($0.19)	$1.82	($12.39)	$0.12	$0.40
Adjusted Weighted Average Basic Shares Outstanding	108.92M	108.85M	109.07M	109.31M	109.34M	109.27M	109.42M	109.53M	109.57M	109.53M	109.66M
Adjusted Diluted Earnings per Share	$8.69	$6.39	$1.10	$1.41	$1.06	($17.50)	($0.19)	$1.81	($12.39)	$0.13	$0.40
Adjusted Weighted Average Diluted Shares Outstanding	109.44M	109.38M	109.51M	109.55M	109.54M	109.27M	109.42M	109.73M	109.57M	109.53M	109.98M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	108.86M	217.81M	109.22M	109.26M	109.31M	109.33M	109.41M	109.50M	109.50M	109.57M	109.66M
Normalized Net Operating Profit after Tax (NOPAT)	249	196	177	258	208	153	137	179	153	91	111
Normalized NOPAT Margin	9.15%	7.63%	6.78%	9.71%	7.86%	6.47%	5.74%	7.05%	6.34%	4.13%	4.76%
Pre Tax Income Margin	26.22%	5.14%	6.01%	6.90%	6.91%	-64.09%	-0.13%	5.33%	-56.22%	0.36%	3.51%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.57	1.21	1.33	1.52	1.57	-8.73	0.85	1.33	-7.17	0.65	1.20
NOPAT to Interest Expense	6.06	7.79	0.98	1.21	0.98	-6.00	0.58	2.07	-5.04	1.19	0.70
EBIT Less CapEx to Interest Expense	3.86	0.49	0.51	0.92	1.05	-9.37	0.35	0.80	-7.53	0.25	0.84
NOPAT Less CapEx to Interest Expense	5.35	7.07	0.17	0.61	0.46	-6.64	0.08	1.54	-5.40	0.79	0.34
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	15.70%	16.09%	16.04%	17.07%	30.24%	-22.46%	-16.31%	-11.71%	-3.77%	-3.74%	-3.88%
Augmented Payout Ratio	15.70%	16.09%	16.04%	17.07%	30.24%	-22.46%	-16.31%	-11.71%	-3.77%	-3.74%	-3.88%

Financials Breakdown Chart

Key Financial Trends

Here are the top takeaways for Celanese (NYSE: CE) based on the quarterly statements from the last four years. The bullets focus on trends that may be meaningful for retail investors, with positives listed first, then neutral, then negatives.

Solid operating cash flow in 2025: Net cash from continuing operating activities was about $406M (Q2), $449M (Q3), and $252M (Q4), indicating ongoing cash generation even as quarterly results fluctuated.
Gross margin remained around 20% across 2025 quarters: Q4 2025 gross margin roughly 19.1% (420M gross profit on 2.204B revenue), Q3 around 21.5%, Q2 about 21.1%, and Q1 about 19.9%.
Positive quarterly earnings signal improving near-term profitability: Q4 2025 net income attributable to common shareholders about $14M with diluted EPS around $0.13, following a tougher Q3.
Healthy near-term liquidity: As of 2025 Q3, Total Current Assets were about $6.09B vs. Total Current Liabilities of about $3.73B, indicating solid working capital.
Approximate free cash flow in Q4 2025 appears constructive: roughly $252M of CFO minus about $84M of capital expenditures equals around $168M of free cash flow for that quarter.
Top-line stability with a revenue band around $2.2B–$2.6B in 2025 quarters (Q4 2.204B, Q3 2.419B, Q2 2.532B, Q1 2.389B) suggests scale remains consistent despite quarterly swings.
Modest ongoing cash returns to shareholders: cash dividends paid were in the low tens of millions per quarter (for example, around $11–$12M per quarter in 2025).
Earnings per share fluctuated in 2025: strong in Q2 (about $1.82), negative in Q1 and especially Q3 (notably large negative EPS in Q3 2025), and positive again in Q4 (about $0.13).
One-time-type earnings weakness in Q3 2025: Total Operating Income was about -$1.28B and Consolidated Net Income/Shareholders' negative in that quarter, indicating a large quarterly swing likely due to non-operating items.
High leverage environment: Long-term debt around $11.7B–$11.9B with total liabilities near $17.6B–$17.9B and total equity about $3.9B–$5.3B across mid-2025, leaving a sizeable net debt load even as cash balances hovered around $1.4B.

05/11/26 11:43 AM ETAI Generated. May Contain Errors.

Celanese Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Celanese's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Celanese's net income appears to be on a downward trend, with a most recent value of -$1.15 billion in 2025, falling from $285 million in 2015. The previous period was -$1.53 billion in 2024. See where experts think Celanese is headed by visiting Celanese's forecast page.

Celanese's total operating income in 2025 was -$786 million, based on the following breakdown:

Total Gross Profit: $1.95 billion
Total Operating Expenses: $2.74 billion

Over the last 10 years, Celanese's total revenue changed from $5.67 billion in 2015 to $9.54 billion in 2025, a change of 68.2%.

Celanese's total liabilities were at $17.22 billion at the end of 2025, a 0.3% decrease from 2024, and a 199.2% increase since 2015.

In the past 10 years, Celanese's cash and equivalents has ranged from $439 million in 2018 to $1.81 billion in 2023, and is currently $1.26 billion as of their latest financial filing in 2025.

Over the last 10 years, Celanese's book value per share changed from 16.21 in 2015 to 36.98 in 2025, a change of 128.1%.

Related Companies

Financial statements for NYSE:CE last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Celanese (CE) Financials

Financials Breakdown Chart

Key Financial Trends

Celanese Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Celanese (CE) Financials

Annual Income Statements for Celanese

Quarterly Income Statements for Celanese

Annual Cash Flow Statements for Celanese

Quarterly Cash Flow Statements for Celanese

Annual Balance Sheets for Celanese

Quarterly Balance Sheets for Celanese

Annual Metrics And Ratios for Celanese

Quarterly Metrics And Ratios for Celanese

Financials Breakdown Chart

Key Financial Trends

Celanese Financials - Frequently Asked Questions

When does Celanese's financial year end?

How has Celanese's net income changed over the last 10 years?

What is Celanese's operating income?

How has Celanese's revenue changed over the last 10 years?

How much debt does Celanese have?

How much cash does Celanese have?

How has Celanese's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools